RADIOLOGY CORNER From: Military Medicine | Date: February 1, 2007| Author: Folio, Les; Sanders, Timothy G; Ly, Justin Q | Copyright Association of Military Surgeons of the United States Feb 2007. Provided by ProQuest LLC.Copyright information

Answer to last month's radiology case and images: Schistosomiasis Japonicum Involving the Liver and Colon (Case # 10 appears at the end of this article)

Introduction: Colonic and hepatic calcifications are characteristic of Schistosomiasis infection of the gastrointestinal tract. Liver biopsy confirmed Schistosomiasis japonicum infection.

The full-text version is available in a downloadable PDF file on the AMSUS page of the USUHS website at: http://rad.usuhs.mil/amsus.html

Related newspaper, magazine, and journal articles from HighBeam Research

	RADIOLOGY CORNER Military Medicine ; Answer to last month's radiology case and images: Schistosomiasis Japonicum Involving the Liver and Colon (Case # 10 appears at the end of this article) Introduction: Colonic and hepatic calcifications are characteristic of Schistosomiasis infection of the gastrointestinal tract. Liver biopsy
	YOUR PROBLEMS: Lily-livered over surgeon's probe; LETTER OF THE DAY.(Features) The Mirror (London, England) ; Byline: Miriam Stoppard SOME time ago I had a blood test which showed an abnormality of my liver. The consultant wasn't sure what was causing it and has suggested a liver biopsy. What does a this entail and is it dangerous? A LIVER biopsy isn't dangerous and is usually performed as a day case -
	Biopsy or Biomarkers: Is There a Gold Standard for Diagnosis of Liver Fibrosis? Clinical Chemistry ; Liver biopsy has long been the gold standard for the grading of hepatic inflammation and the staging of hepatic fibrosis, and has been used as the reference standard method in evaluations of plasma markers of liver disease. In the modern era with the use of ultrasound guidance, biopsy is an
	Liver biopsy may become more of a prognostic than diagnostic test.(Digestive Disorders) Family Practice News ; Philadelphia -- Liver biopsy is losing its appeal as a diagnostic tool for chronic liver disease, Dr. K. Rajender Reddy said at the annual meeting of the American College of Physicians. Problems associated with liver biopsy such as sampling error, inadequate specimens, and interobserver variability
	Liver biopsy and screening for cancer in hepatitis C.(Editorials) American Family Physician ; In June of 2002, the National Institutes of Health (NIH) convened a consensus development conference on the management of hepatitis C. (1) This conference differed from a previous conference (2) on management of hepatitis C by including presentations from a detailed systematic review of evidence on
	Iatrogenic gallbladder perforation: Conservative management by percutaneous drainage and cholecystostomy The American Surgeon ; Gallbladder perforation is an uncommon complication of percutaneous liver biopsy. Diagnosis is usually made clinically and management has traditionally been by cholecystectomy. We report a case of gallbladder perforation secondary to percutaneous liver biopsy diagnosed by dimethyl iminodiacetic
	Liver Biopsy Evaluation: Histologic Diagnosis and Clinical Correlations Mayo Clinic Proceedings ; Liver Biopsy Evaluation: Histologic Diagnosis and Clinical Correlations, by Gary C. Kanel and Jacob Korula, 255 pp, with illus, $139, Philadelphia, Pa, WB Saunders Co (telephone: 800-- 545-2522),2000,ISBN 0-7216-7692-8 Type of Book: Dual-authored by a pathologist and a gastroenterologist, this
	Device may reduce liver biopsy rate.(News) Internal Medicine News ; A new device for noninvasively measuring liver fibrosis could decrease the number of liver biopsies performed on patients with chronic hepatitis C. especially when used with other noninvasive tests. The device, called FibroScan, might bring more patients with chronic hepatitis C to a clinic for
	MRI method may oust liver biopsy for sickle cell.(Clinical Rounds) Family Practice News ; ATLANTA -- Children with sickle cell disease, [beta]-thalassemia, and other hematologic diseases may no longer need to undergo potentially painful and risky biopsies to assess the amount of iron accumulating in their liver as a result of therapeutic blood transfusions--at least at one hospital.
	Noninvasive device measures liver fibrosis.(Clinical Rounds) Family Practice News ; A new device for noninvasively measuring liver fibrosis could decrease the number of liver biopsies performed on patients with chronic hepatitis C, especially when it is combined with other noninvasive tests. The device, called FibroScan, might bring more patients with chronic hepatitis C to a

See all results.